Copper Peptides in Research: GHK-Cu and AHK-Cu
For laboratory research use only. Not for human or veterinary use.

Copper peptides are among the most-studied compounds in dermatological and connective-tissue research literature. Here's what they are, why the copper matters, and how they differ from one another.
What makes a copper peptide#
A copper peptide is a short amino acid sequence bound to a copper(II) ion. The peptide acts as a chelator — it holds the metal ion in a specific geometric arrangement rather than leaving it free in solution.
That distinction is the whole point. Free copper ions are reactive and can drive oxidative chemistry indiscriminately. Bound into a peptide complex, the copper is delivered in a controlled, stable form, and the complex behaves as a discrete molecule with its own binding characteristics.
The blue colour of a reconstituted copper peptide solution comes from the copper complex itself. It is expected, not a sign of contamination.
GHK-Cu#
GHK is glycyl-L-histidyl-L-lysine — a tripeptide first isolated from human plasma in the 1970s. Bound to copper it becomes GHK-Cu.
Research literature focuses on its interaction with extracellular matrix components. Published work examines its relationship to collagen and elastin synthesis pathways, matrix metalloproteinase regulation, and gene-expression profiles in fibroblast models. It appears widely in studies of tissue remodelling and skin-science research.
GHK-Cu is the most extensively documented compound in this group, with a research literature spanning several decades.
AHK-Cu#
AHK is alanyl-L-histidyl-L-lysine. Structurally similar to GHK — the glycine at position one is replaced by alanine — and likewise studied as a copper complex.
The research emphasis differs. AHK-Cu appears predominantly in hair-follicle literature, particularly work examining dermal papilla cell models and follicular growth-phase signalling. The two compounds are frequently studied side by side precisely because the single-residue difference produces different research profiles.
Handling copper peptides in the laboratory#
Copper complexes have practical quirks worth knowing:
Light sensitivity. Copper peptide solutions degrade faster under light exposure than many other peptides. Amber vials and dark storage are standard practice.
Solvent choice matters. Bacteriostatic water is the usual choice for multi-draw work. Some protocols specify sterile water. See our solvent guide for the distinction.
Colour is diagnostic. A clear blue solution is normal. Cloudiness, particulates or a colour shift toward green or brown suggests degradation or contamination — discard rather than use.
Don't shake. As with all peptides, swirl gently. Agitation denatures peptide structure. Full technique in our reconstitution guide.
Cold storage. Lyophilised at 2–8°C protected from light; reconstituted material refrigerated and used within its stability window. See storage guidance.
Blends containing copper peptides#
Copper peptides appear in several multi-compound research blends, combined with repair-focused compounds. Where a blend contains GHK-Cu, the same handling considerations apply to the whole preparation — light protection, gentle reconstitution, cold storage.
Sourcing considerations#
Two points specific to this group:
Copper content should be specified. The complex has a defined stoichiometry. A certificate that reports peptide purity without addressing the copper component is incomplete for a metal complex.
Colour is not a purity indicator. A vivid blue solution tells you copper is present. It tells you nothing about the purity of the peptide or whether the sequence is correct. That still requires HPLC and mass spectrometry.
Sources#
Status elsewhere: GHK-Cu is widely used as an ingredient in cosmetic products.
Each entry links to its PubMed record, where the title and abstract can be read. The descriptions are ours: they say what each paper examined, not what it is claimed to show. Records checked on PubMed on 28 October 2026.
- Pickart L, Thaler MM (1973). Nat New Biol 243(124):85–7. The 1973 report of a tripeptide from human serum, the starting point of the GHK literature. PubMed 4349963
- Pickart L, Margolina A (2018). Int J Mol Sci 19(7):1987. Review of GHK-Cu research by the group that first described it. The authors list a skin-care company as their affiliation. PubMed 29986520
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR (2025). Bioimpacts 15:30071. Independent review of GHK and GHK-Cu as topical cosmetic ingredients, covering cell studies, skin permeability and formulation. Notes that GHK-Cu is widely used in cosmetic products. PubMed 39963574
- Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. (2026). Pharmaceutics 18(9):1077. Independent systematic evidence-mapping review. Finds the clinical evidence sparse, and that many studies do not define the copper complex they actually tested. PubMed 42797253
- Pyo HK, Yoo HG, Won CH, et al. (2007). Arch Pharm Res 30(7):834–9. Laboratory study of AHK-Cu on human hair follicles kept in culture and on dermal papilla cells. PubMed 17703734
In our catalogue#
- GHK-Cu — collagen and matrix research
- AHK-Cu — hair follicle research
- GLOW Blend — GHK-Cu with repair compounds
- KLOW Blend — four-compound research blend
Ask about the documentation for the batch we would ship before you order.
Pioneer Research Peptides — UK supplier of research peptides.
For laboratory research use only — not for human consumption. 18+.
Research peptides from UK stock#
Supplied for laboratory research use only. Ask about the documentation for a batch before you order.
